Luc Mainville

Luc Mainville is the Senior Vice-President and Chief Financial Officer at Valeo Pharma. Luc has over 25 years of experience in the pharmaceutical and biotech industry. Prior to joining Valeo Pharma, Luc was the Operating Chairman at PIGA Inc., a leader in the development and manufacturing of novel sports footwear. Luc has also served as the Interim President and Chief Executive Officer at Acerus Pharma, a Canadian pharmaceutical company focused on the development, manufacture, marketing and distribution of innovative, branded products that improve the patient experience. In addition, Luc has served on the Board of Directors for Zucara Therapeutics Inc. and AAA Médic Montréal. Luc holds a Bachelor of Science in Pharmacy from the University of Montreal and is a member of the Ordre des pharmaciens du Québec.

Luc Mainville has an MBA from McGill University in international marketing & finance and a masters from UQAM in business administration.

Luc Mainville reports to Steve Saviuk, Chief Executive Officer. Luc Mainville works with Helen Saviuk - Vice-President, Operations, Paul Allard - Vice-President, Legal Affairs and Corporate Secretary, and Jeff Skinner - Vice-President, Business Development.